SEC Form D private-offering filing

Commense Bio, Inc.

Name: Commense Bio, Inc. - new SEC Form D private-offering filing, Boulder, CO
Published: 2026-06-12

A new SEC Form D private-offering notice from Boulder, CO, a $2,671,875 filer-stated offering target in Biotech. The source filing is one click away.

Commense Bio, Inc. Verified via SEC Form D

Biopharmaceutical company developing genetically engineered bacterial therapeutics (Safety Switched strains) to treat invasive infections such as MRSA/MSSA, recurrent UTIs, and cystic fibrosis-related lung infections.

Filed 2026-06-12Filed to raise $2,671,875First money in 2026-01-18Raised so far $2,470,334HQ (as filed) Boulder, COSector Biotech ✓Stage (inferred) SeedCall status Late filing

Source linked the Form D on EDGAR↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Colorado →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.